Gastroenterology

Danese S, Pravin K, Yang J, Le Moine J, Khan S, Hawe E. Vedolizumab rate of mucosal healing in Crohn's disease: a systematic literature review and meta-analysis of real-world data. Poster presented at the 2021 Virtual Digestive Disease Week (DDW) Conference; May 21, 2021.


Abstract not available at this time.

Osborne RH, Nelson L, Elsworth GR, Fehnel S, Williams N, Bender RH, Ziemiecki R, Gymnopoulou E, De Paepe E, Norcross L, Heijnen E, Ispas G, Cheret A, Comeaux C, Chan E, Scott JA. Psychometric evaluation of the Respiratory Infection Intensity and Impact Questionnaire Version 2 (RiiQTMv2) symptom scores for respiratory syncytial virus. Poster presented at the Virtual ISPOR 2021 Conference; May 2021.


Ayodele O, Parikh RC, Esterberg E, Ajmera M, Goodwin B, Desai NK, Williams J, Katzka DA. Characterizing the burden of disease in younger children, adults, and older adults with eosinophilic esophagitis in a real world setting. Poster presented at the ACG 2020 Virtual Annual Scientific Meeting; October 23, 2020.


INTRODUCTION: There is a need to understand how burden of disease, treatment patterns and disease progression vary in different age groups of patients with eosinophilic esophagitis (EoE) in a real-world setting.

Ayodele O, Parikh RC, Ajmera A, Esterberg E, Desai NK, Williams J, Katzka DA. Assessing the diagnostic journey, burden of disease, and treatment patterns in patients with eosinophilic esophagitis in a real world setting. Poster presented at the ACG 2020 Virtual Annual Scientific Meeting; October 23, 2020.


INTRODUCTION: This retrospective observational cohort study assessed the diagnostic journey, burden of disease and treatment patterns in patients with eosinophilic esophagitis (EoE) in a real-world setting.

Boklage S, Mangel AW, Ramamohan V, Mladsi DW, Wang T. Cost-effectiveness of noninvasive active tests for universal post-treatment confirmation of eradication of H. pylori infection. Poster presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology; October 2014. Philadelphia, PA.


Boklage SH, Mangel AW, Ramamohan V, Mladsi DM, Wang T. Effects of patient compliance on the cost-effectiveness of non-invasive tests for initial diagnosis of H. pylori infection in a high prevalence population. Poster presented at the 79th Annual Scientific Meeting of the American College of Gastroenterology; October 17, 2014. Philadelphia, PA.


Purser M, Hartley L, Earnshaw S, Bhaila R, Nag A. Systematic literature review to assess the healthcare resource use and costs associated with ulcerative colitis in adults in Europe. Poster presented at the 2020 Virtual UEG Week Conference; October 11, 2020.


Abstract not available at this time.

Purser M, Hartley L, Earnshaw S, Bhaila R, Nag A. Economic models used to evaluate the cost-effectiveness of biologic treatments for ulcerative colitis: a systematic literature review. Poster presented at the 2020 Virtual UEG Week Conference; October 11, 2020.


Abstract not available at this time.

Ruigomez A, Plana E, Gilsenan A, Fortuny J, Cainzos-Achirica M, Flynn RWV, MacDonald TM, Garcia-Rodriguez L, Ziemiecki R, Andrews EB. Identification and validation of major cardiovascular events in the United Kingdom data sources included in a multi-database post-authorization safety study of prucalopride. Drug Saf. 2021 May;44(5):541-51. doi: 10.1007/s40264-021-01044-4


Ronquest N, La L, Nag A. The economic burden of inflammatory bowel disease in Japan: results from a systematic literature review. Poster presented at the 2020 Virtual Japan Digestive Disease Week Conference; November 2020.


BACKGROUND: Inflammatory bowel disease (IBD), including Crohn’s disease (CD) and ulcerative colitis (UC), is a chronic, relapsing–remitting condition requiring lifelong management. With increasing therapeutic options in Japan, a clear understanding of the economic burden of IBD is critical.

Subscribe to Gastroenterology

How Can We Help You?